1170 related articles for article (PubMed ID: 17427340)
1. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties.
Ulrich-Vinther M; Schwarz EM; Pedersen FS; Søballe K; Andreassen TT
Bone; 2005 Dec; 37(6):751-8. PubMed ID: 16169783
[TBL] [Abstract][Full Text] [Related]
5. Biological effects of rAAV-caAlk2 coating on structural allograft healing.
Koefoed M; Ito H; Gromov K; Reynolds DG; Awad HA; Rubery PT; Ulrich-Vinther M; Soballe K; Guldberg RE; Lin AS; O'Keefe RJ; Zhang X; Schwarz EM
Mol Ther; 2005 Aug; 12(2):212-8. PubMed ID: 16043092
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
[TBL] [Abstract][Full Text] [Related]
7. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure.
Zhang T; Yu H; Gong W; Zhang L; Jia T; Wooley PH; Yang SY
Biomaterials; 2009 Oct; 30(30):6102-8. PubMed ID: 19665222
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage.
Madry H; Cucchiarini M; Terwilliger EF; Trippel SB
Hum Gene Ther; 2003 Mar; 14(4):393-402. PubMed ID: 12659680
[TBL] [Abstract][Full Text] [Related]
9. In vivo gene delivery to articular chondrocytes mediated by an adeno-associated virus vector.
Ulrich-Vinther M; Duch MR; Søballe K; O'Keefe RJ; Schwarz EM; Pedersen FS
J Orthop Res; 2004 Jul; 22(4):726-34. PubMed ID: 15183427
[TBL] [Abstract][Full Text] [Related]
10. LMP-1 retroviral gene therapy influences osteoblast differentiation and fracture repair: a preliminary study.
Strohbach CA; Rundle CH; Wergedal JE; Chen ST; Linkhart TA; Lau KH; Strong DD
Calcif Tissue Int; 2008 Sep; 83(3):202-11. PubMed ID: 18709396
[TBL] [Abstract][Full Text] [Related]
11. The use of recombinant adeno-associated virus for skeletal gene therapy.
Dai J; Rabie AB
Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
[TBL] [Abstract][Full Text] [Related]
12. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2.
Cucchiarini M; Madry H; Ma C; Thurn T; Zurakowski D; Menger MD; Kohn D; Trippel SB; Terwilliger EF
Mol Ther; 2005 Aug; 12(2):229-38. PubMed ID: 16043094
[TBL] [Abstract][Full Text] [Related]
13. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis.
Goater J; Müller R; Kollias G; Firestein GS; Sanz I; O'Keefe RJ; Schwarz EM
J Rheumatol; 2000 Apr; 27(4):983-9. PubMed ID: 10782827
[TBL] [Abstract][Full Text] [Related]
14. Effect of BMP-2 gene transfer on bone healing in sheep.
Egermann M; Lill CA; Griesbeck K; Evans CH; Robbins PD; Schneider E; Baltzer AW
Gene Ther; 2006 Sep; 13(17):1290-9. PubMed ID: 16642029
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
[TBL] [Abstract][Full Text] [Related]
16. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep.
Egermann M; Baltzer AW; Adamaszek S; Evans C; Robbins P; Schneider E; Lill CA
Hum Gene Ther; 2006 May; 17(5):507-17. PubMed ID: 16716108
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer.
Gelse K; Jiang QJ; Aigner T; Ritter T; Wagner K; Pöschl E; von der Mark K; Schneider H
Arthritis Rheum; 2001 Aug; 44(8):1943-53. PubMed ID: 11508447
[TBL] [Abstract][Full Text] [Related]
18. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.
Carmody EE; Schwarz EM; Puzas JE; Rosier RN; O'Keefe RJ
Arthritis Rheum; 2002 May; 46(5):1298-308. PubMed ID: 12115237
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.
Lamoureux F; Richard P; Wittrant Y; Battaglia S; Pilet P; Trichet V; Blanchard F; Gouin F; Pitard B; Heymann D; Redini F
Cancer Res; 2007 Aug; 67(15):7308-18. PubMed ID: 17671200
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 gene therapy to protect articular cartilage in a rat model of joint damage.
Izal I; Acosta CA; Ripalda P; Zaratiegui M; Ruiz J; Forriol F
Arch Orthop Trauma Surg; 2008 Feb; 128(2):239-47. PubMed ID: 17661064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
